The role of chemokines and their receptors in cardiovascular diseases

Read full text
Authors: Sashwath Srikanth, Louis DeVito, Nicholas J Constantinesco, Radha Krishna Gopal
Cited by: 4
References: 135

Abstract

Cardiovascular diseases (CVD) are increasingly recognized as an outcome of multiple inflammatory processes. Despite a large recent research focus, the majority of attempts to therapeutically target chemokines, have not been successful. Thus, a better understanding of the mechanisms involving chemokines contributing to CVD is warranted to identify the missing gaps in the field. This review summarizes the latest developments on the role of chemokines in the pathogenesis of atherosclerosis, heart failure (HF), coronary artery disease, myocarditis, cardiomyopathy, and arrhythmias. We also aim to provide insight into the current clinical trials and potential therapeutics targeting chemokines and their receptors.

Fields of Study & Subjects

Chemokine receptors and signaling Cardiac Fibrosis and Remodeling Viral Infections and Immunology Research

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1758588–1758588
Publication date
4 February 2026
Language
EN